Founded by pioneers in biopharmaceuticals, Renova Therapeutics is developing a portfolio of definitive gene and peptide therapies to restore health to people suffering from cardiovascular and metabolic diseases.
Our investigational therapies are based on carefully validated and proprietary research into disease mechanisms and the founders’ nearly 50 combined years of work in the gene therapy field. This experience enables us to generate an entirely original platform of therapeutics and delivery systems that in a single dose are designed to provide durable, life-long treatments for chronic diseases.
Our scientific research, led by Dr. H. Kirk Hammond, appears in numerous peer-reviewed articles that establish the scientific rationale and evidence supporting the development of our pipeline and our novel approach to delivering gene therapies.
The first indications the company is pursuing are gene therapy treatments for congestive heart failure (CHF) and type 2 diabetes, two of the most common and devastating chronic diseases in the world. The company’s lead product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in millions of patients with CHF. The Renova Therapeutics pipeline also includes a groundbreaking gene therapy in preclinical stage for sufferers of type 2 diabetes, as well as a peptide infusion therapy for the treatment of acute decompensated heart failure.
OUR MISSION: Creating transformational gene and peptide therapies that treat the most prevalent diseases to restore health and renew life
OUR VISION: A future in which we are able to permanently treat chronic diseases with gene and peptide therapies
Company Details
- Employees
- 7
- Founded
- -
- Address
- 11455 El Camino Real, Suite 350, San Diego,ca 92130,united States
- Phone
- (858) 461-1837
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- renovatherapeutics.com
- HQ
- San Diego, CA
Renova Therapeutics Questions
Renova Therapeutics's helpline number is (858) 461-1837
Renova Therapeutics's website is renovatherapeutics.com
Renova Therapeutics's LinkedIn profile is https://www.linkedin.com/company/renova-therapeutics
Renova Therapeutics has
7 employees.
View email and phone details for 7
employees at Renova Therapeutics.
Renova Therapeutics's industry is
Biotechnology Research
Renova Therapeutics's top competitors are
Replicate Bioscience, Inc.,
Sling Therapeutics,
Qoolabs, Inc.,
Xylocor Therapeutics, Inc.,
Skye Bioscience Inc.,
Qualigen Therapeutics,
Origami Therapeutics, Inc.,
Denovicon Therapeutics,
Regenxbio,
Biosplice Therapeutics.
Renova Therapeutics's support email address is info@renovatherapeutics.com
Renova Therapeutics's categories are Biotechnology Research
Renova Therapeutics's founding year is 2009
